Stryker signs definitive agreement to acquire Amplitude Vascular Systems, enhancing its cardiology portfolio with next-generation intravascular lithotripsy technology for Asian hospital networks.

Global investment firm Carlyle has acquired majority stakes in two leading US healthcare revenue cycle management firms, enhancing operational efficiency for hospitals nationwide.

GE HealthCare announces FDA approval for its latest AI-enhanced ultrasound platform, revolutionizing real-time patient monitoring in American hospital critical care units.

Philips earns a spot among the Financial Times' top 3 medtech companies to work for in Asia in 2026, highlighting its diagnostic imaging systems and patient monitoring technologies for hospitals.[2]

Korea will showcase groundbreaking AI-driven healthcare innovations at WHX Bangkok and Medtec Southeast Asia 2026, positioning Thailand as ASEAN's medical gateway.

Ridgetech, a leading Chinese wholesaler of pharmaceuticals and healthcare products, launches a dual-engine strategy targeting 30% B2B customer growth and expanded market reach.

The US FDA has approved a groundbreaking AI-driven diagnostic imaging platform set to revolutionize cardiology workflows in American hospitals by improving accuracy and speed.

AIA's latest report reveals Asia's healthcare systems are under severe pressure from aging populations, surging demand, and medical inflation, urging stronger payer-provider collaboration.

Select Medical Holdings Corporation will disclose its first quarter 2026 financial results today, providing key insights into its hospital and critical care operations.

SQ Innovation has reached two key regulatory milestones as part of its international expansion plans for Lasix® ONYU. The company has obtained CE marking for the device and has also received confirmatio